S Ohta Selected Research

S Ohta Research Topics

Disease

17	Neoplasms (Cancer) 05/2015 - 04/2000
12	Asthma (Bronchial Asthma) 01/2018 - 01/2001
9	Inflammation (Inflammations) 01/2018 - 06/2000
6	Parkinson Disease (Parkinson's Disease) 04/2009 - 01/2000
5	Prostatic Neoplasms (Prostate Cancer) 01/2002 - 03/2000
4	Fibrosis (Cirrhosis) 04/2013 - 11/2001
3	Neoplasm Metastasis (Metastasis) 06/2008 - 03/2000
3	Breast Neoplasms (Breast Cancer) 11/2006 - 08/2000
3	MELAS Syndrome (Syndrome, MELAS) 11/2002 - 02/2000
3	Pituitary Neoplasms (Pituitary Adenoma) 01/2002 - 08/2000
3	Ischemia 11/2001 - 01/2000
3	Alzheimer Disease (Alzheimer's Disease) 12/2000 - 06/2000
2	Hypersensitivity (Allergy) 11/2017 - 01/2001
2	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2016 - 08/2014
2	Thromboembolism 02/2010 - 08/2009
2	Hypoxia (Hypoxemia) 06/2008 - 08/2006
2	Pneumonia (Pneumonitis) 03/2008 - 07/2001
2	Lung Neoplasms (Lung Cancer) 03/2008 - 05/2000
2	Dyspnea (Shortness of Breath) 03/2008 - 07/2000
2	Obesity 08/2006 - 06/2000
2	Necrosis 04/2005 - 04/2000
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2005 - 05/2003
2	Hemorrhage 05/2003 - 07/2001
2	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2003 - 03/2000
2	Essential Hypertension 11/2002 - 01/2002
2	Carcinoma (Carcinomatosis) 12/2001 - 04/2000
2	Hypertrophy 10/2001 - 10/2000
2	Mitochondrial Diseases (Mitochondrial Disease) 09/2001 - 02/2000
2	MERRF Syndrome (Myoclonic Epilepsy and Ragged Red Fibers) 09/2001 - 02/2000
2	Myoclonic Epilepsies (Myoclonic Encephalopathy) 09/2001 - 02/2000
2	Rhabdoid Tumor (Rhabdoid Tumors) 09/2001 - 03/2001
2	Rheumatoid Arthritis 08/2001 - 08/2001
2	Melanoma (Melanoma, Malignant) 05/2001 - 10/2000
2	Multiple System Atrophy 05/2001 - 07/2000
2	Parkinsonian Disorders (Parkinsonism) 05/2001 - 12/2000
2	Mitochondrial Encephalomyopathies (Mitochondrial Encephalomyopathy) 10/2000 - 02/2000
1	Head and Neck Neoplasms (Head and Neck Cancer) 02/2018
1	Otitis Media with Effusion 02/2018
1	Rhinosinusitis 11/2017
1	Cholangiocarcinoma 10/2017
1	Atherosclerotic Plaque (Atheroma) 09/2015
1	Rhabdomyosarcoma 05/2015
1	Ewing Sarcoma (Sarcoma, Ewing) 05/2015

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 05/2015 - 02/2000
7	PeriostinIBA 01/2018 - 05/2011
7	Biomarkers (Surrogate Marker)IBA 01/2018 - 05/2011
5	CytokinesIBA 08/2014 - 06/2000
4	Monoclonal AntibodiesIBA 10/2016 - 01/2000
4	EnzymesIBA 08/2014 - 08/2000
4	AntigensIBA 03/2008 - 07/2000
4	Prostate-Specific Antigen (Semenogelase)IBA 01/2002 - 01/2001
3	AllergensIBA 01/2018 - 04/2006
3	Natural Killer Cell ReceptorsIBA 02/2003 - 03/2000
3	AminesIBA 01/2003 - 01/2000
3	NucleotidesIBA 11/2002 - 02/2000
3	Ethylene Glycol (Monoethylene Glycol)IBA 02/2002 - 08/2000
3	DipeptidesIBA 02/2002 - 08/2000
3	Immunoconjugates (Immunoconjugate)IBA 02/2002 - 08/2000
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2001 - 06/2000
3	Transfer RNA (tRNA)IBA 09/2001 - 02/2000
3	AnticodonIBA 09/2001 - 02/2000
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 11/2001
2	Immunoglobulin E (IgE)IBA 01/2018 - 10/2016
2	SteroidsIBA 05/2014 - 04/2000
2	GlucocorticoidsIBA 05/2014 - 04/2000
2	EdaravoneIBA 02/2010 - 08/2009
2	FibrinIBA 02/2010 - 08/2009
2	RotenoneIBA 04/2009 - 12/2003
2	Indicators and Reagents (Reagents)IBA 01/2009 - 12/2001
2	SolutionsIBA 07/2008 - 08/2000
2	Messenger RNA (mRNA)IBA 06/2008 - 01/2000
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2007 - 07/2000
2	Mitochondrial DNA (mtDNA)IBA 08/2006 - 11/2002
2	Leu Transfer RNAIBA 01/2005 - 03/2004
2	1,2,3,4- tetrahydro- 1- (phenylmethyl)isoquinolineIBA 01/2003 - 07/2001
2	Peptides (Polypeptides)IBA 02/2002 - 10/2000
2	AgarIBA 01/2002 - 10/2000
2	Antihypertensive Agents (Antihypertensives)IBA 01/2002 - 06/2000
2	LipidsIBA 10/2001 - 02/2000
2	Lys Transfer RNAIBA 09/2001 - 02/2000
2	Hormones (Hormone)IBA 09/2001 - 04/2000
2	AldehydesIBA 12/2000 - 06/2000
2	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 11/2000 - 05/2000
2	Valine (L-Valine)FDA Link 10/2000 - 08/2000
2	DuocarmycinsIBA 10/2000 - 08/2000
2	ThermolysinIBA 10/2000 - 08/2000
2	HLA-C Antigens (HLA-C)IBA 08/2000 - 03/2000
2	Cytochromes c (Cytochrome c)IBA 05/2000 - 01/2000
1	Genetic Markers (Genetic Marker)IBA 08/2017
1	anti-IgE antibodiesIBA 10/2016
1	Omalizumab (Xolair)FDA Link 10/2016
1	squamous cell carcinoma-related antigenIBA 06/2016
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 09/2015

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 11/2006 - 04/2000
3	Therapeutics 04/2005 - 04/2000
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 02/2003 - 03/2000
2	Radiotherapy 02/2018 - 01/2010
2	Prostatectomy (Retropubic Prostatectomy) 01/2002 - 03/2001
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 02/2018
1	Pancreaticoduodenectomy 10/2017